Chapters authored
Medical Treatment of Cystic Echinococcosis
Medical treatment in cystic echinococcosis is limited; albendazole remains the gold treatment for patients with low hydatid cysts or those with inoperable echinococcosis. Due to uncommon side effects, administration may be continuous (cycles of 28 days with a break of 14 days between courses) as well as discontinuous over long periods of time. In recent years, there have been many concerns for the testing of various substances and drugs against Echinococcus granulosus, both in vitro and in vivo, on the animal model, but the results have not been satisfactory. New clinical trials are required, as well as the development of an effective vaccine to limit the spread of echinococcosis in endemic areas.
Part of the book: Overview on Echinococcosis
Side Effects of the COVID-19 Vaccines
Vaccination against COVID-19 was one of the most important discoveries in the fight against the pandemic and saved millions of lives. As with any vaccine, side effects have been reported, but the benefit of vaccination is much more important and should be considered. The most common side effects are mild to moderate, especially at the injection site, as well as self-limiting; non–life-threatening systemic reactions and severe reactions after vaccination are rare. In this chapter, the author will describe all types of side effects related to COVID-19 vaccines, information obtained from Web of Science, PubMed, Medline, Embase, Cochrane Library, Centre for Disease Control Prevention (CDC), cdc.gov database, and Vaccine Adverse Event Reporting System (VAERS).
Part of the book: COVID-19 Vaccines